IRIS
PERUCCA, EMILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.313
AS - Asia 10.514
EU - Europa 7.740
SA - Sud America 1.251
AF - Africa 334
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 11
Totale 34.191
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.045
CN - Cina 5.194
SG - Singapore 2.345
IE - Irlanda 1.775
UA - Ucraina 1.382
HK - Hong Kong 1.128
BR - Brasile 942
DE - Germania 875
RU - Federazione Russa 797
VN - Vietnam 770
FI - Finlandia 619
FR - Francia 566
IT - Italia 464
SE - Svezia 454
GB - Regno Unito 446
IN - India 224
BD - Bangladesh 175
CA - Canada 151
ZA - Sudafrica 147
AR - Argentina 95
IQ - Iraq 89
JP - Giappone 87
MX - Messico 69
TR - Turchia 69
PL - Polonia 65
PK - Pakistan 59
NL - Olanda 57
ID - Indonesia 53
CO - Colombia 46
UZ - Uzbekistan 42
VE - Venezuela 41
SA - Arabia Saudita 40
EC - Ecuador 38
BE - Belgio 36
ES - Italia 34
KE - Kenya 34
MY - Malesia 32
PH - Filippine 31
CL - Cile 30
AT - Austria 29
EG - Egitto 27
TN - Tunisia 26
IL - Israele 23
AU - Australia 22
MA - Marocco 22
AE - Emirati Arabi Uniti 20
PE - Perù 20
LT - Lituania 19
PY - Paraguay 17
IR - Iran 16
CZ - Repubblica Ceca 15
MU - Mauritius 14
DZ - Algeria 13
JO - Giordania 13
KR - Corea 13
SI - Slovenia 12
AZ - Azerbaigian 11
ET - Etiopia 10
SK - Slovacchia (Repubblica Slovacca) 10
BG - Bulgaria 9
EU - Europa 9
NP - Nepal 9
PS - Palestinian Territory 9
UY - Uruguay 9
CH - Svizzera 8
RO - Romania 8
SN - Senegal 8
TH - Thailandia 8
GR - Grecia 7
JM - Giamaica 7
KZ - Kazakistan 7
PA - Panama 7
TW - Taiwan 7
BO - Bolivia 6
BY - Bielorussia 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
NI - Nicaragua 6
AL - Albania 5
AO - Angola 5
EE - Estonia 5
HN - Honduras 5
HR - Croazia 5
MD - Moldavia 5
NO - Norvegia 5
LV - Lettonia 4
OM - Oman 4
QA - Qatar 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BH - Bahrain 3
GA - Gabon 3
HU - Ungheria 3
LB - Libano 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SR - Suriname 3
BJ - Benin 2
Totale 34.126
Salva come PNG Salva come JPEG
Città #
Chandler 1.861
Dublin 1.775
Jacksonville 1.663
San Jose 1.379
Nanjing 1.224
Singapore 1.200
Ashburn 1.109
Dallas 1.106
Hong Kong 1.103
Boardman 618
Beijing 563
Nanchang 472
Princeton 448
Lawrence 417
Wilmington 412
Lauterbourg 371
Shenyang 360
Changsha 354
Hebei 347
Los Angeles 327
Ho Chi Minh City 279
Jiaxing 279
Medford 270
Tianjin 218
Hangzhou 197
Hanoi 187
Buffalo 185
Council Bluffs 185
Ann Arbor 175
Redondo Beach 164
Helsinki 160
New York 134
Woodbridge 127
Johannesburg 120
Moscow 114
Milan 111
Shanghai 102
Fairfield 91
São Paulo 86
Saint Petersburg 85
Houston 81
Tokyo 75
Verona 72
Norwalk 71
Chicago 68
Munich 67
The Dalles 64
Toronto 64
Santa Clara 59
Orem 58
Frankfurt am Main 54
San Francisco 54
Seattle 54
Cambridge 51
Brooklyn 46
Des Moines 44
Warsaw 43
Columbus 41
Chennai 38
Da Nang 38
Guangzhou 38
Baghdad 37
Tashkent 36
Zhengzhou 36
Brussels 33
London 33
Kunming 32
Nuremberg 30
Pune 29
Pavia 28
Turku 28
Falls Church 27
Jinan 27
Montreal 27
Atlanta 26
Nairobi 26
Falkenstein 25
Haiphong 25
Rio de Janeiro 25
Charlotte 23
Dearborn 23
Denver 23
Dhaka 23
Mexico City 23
Amsterdam 20
Belo Horizonte 20
Curitiba 20
Piscataway 20
Taizhou 20
Phoenix 19
Manchester 18
Mumbai 18
Washington 18
Jeddah 17
Lahore 17
Tunis 17
Boston 16
Cairo 16
Caracas 16
Guarulhos 16
Totale 22.491
Salva come PNG Salva come JPEG
Nome #
Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and puerperium. 181
A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. 181
A simple and rapid HPLC-UV method for the determination of retigabine in human plasma 169
ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology 166
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbamazepine in healthy women 164
A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma 163
A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. 162
A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study 159
A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. 157
Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. 155
Alterazioni del campo visivo in soggetti epilettici in trattamento cronico con vigabatrin. 154
No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk—An analysis of Finnish health register and German health insurance data 152
A Double-Blind, Placebo-Controlled Study on the Effect of Vigabatrin on In Vivo Parameters of Hepatic Microsomal Enzyme Induction and on the Kinetics of Steroid Oral Contraceptives in Healthy Female Volunteers 147
A PHARMACOLOGICAL AND CLINICAL REVIEW ON TOPIRAMATE, A NEW ANTIEPILEPTIC DRUG, 142
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry 142
Basal Ganglia Dysmorphism in Patients With Aicardi Syndrome 142
A Prospective study on the effects of antiepileptic drugs on the human foetus: The European Registry initiative 139
Low risk pragmatic trials do not always require participants' informed consent 137
Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. 136
ILAE Official Report: A practical clinical definition of epilepsy 132
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. on behalf of the SOPHIE Study Group. 131
Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. 131
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. 127
Drug interactions with nimesulide. 126
A web-based algorithm to rapidly classify seizures for the purpose of drug selection 125
Increased Apparent Oral Clearance of Valproic Acid during Intake of Combined Contraceptive Steroids in Women with Epilepsy 123
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 123
Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. 120
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. 120
Clinical pharmacokinetics of fluvoxamine. 120
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients. 117
Antiepileptic drug use and epileptic seizures in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first survey 117
Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age 117
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 116
Concentrations of L-dopa in plasma and plasma ultrafiltrates. 116
Choreiform syndrome associated with fluoxetine treatment in a patient with deficient CYP2D6 activity. 116
Novel Medications for Epilepsy 115
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.SOPHIE Study Group. 115
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia (Oxford) 51, 1069-1077, 2010 115
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring 115
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 115
Omeprazole Does Not Enhance the Metabolism of Phenacetin, a Marker of CYP1A2 Activity, in Healthy Volunteers 114
Effects of phenytoin on the in vivo kinetics of thiamine and its phosphoesters in rat nervous tissues 114
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Commentary. 114
Effect of active and passive cigarette smoking on CYP1A2-mediated phenacetin disposition in Chinese subjects. 114
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe 114
2017 International League Against Epilepsy classifications of seizures and epilepsy are steps in the right direction 113
Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience 112
Influence of aging on serum phenytoin concentrations: A pharmacokinetic analysis based on therapeutic drug monitoring data. 108
Daytime sleepiness in healthy university students: A multiparametric study 108
Enantioselective effects of levodropropizine and dropropizine on psychomotor functions in normal volunteers: a placebo-controlled, double-blind comparative study. 107
A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy 107
Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers. 107
Development and validation of an HPLC-UV assay for the therapeutic monitoring of the new antiepileptic drug perampanel in human plasma 107
Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs. 107
Pharmacokinetic variability of new antiepileptic drugs at different ages. 106
The new antiepileptic drugs: Pharmacological and clinical aspects. 106
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. 106
THE INFLUENCE OF OLD AGE AND ENZYME INDUCING COMEDICATION ON THE PHARMACOKINETICS OF VALPROIC ACID AT STEADY STATE: A CASE-MATCHED EVALUATION BASED ON THERAPEUTIC DRUG MONITORING DATA. 106
Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers. 105
Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. 104
Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation 104
Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). 104
Valproic acid after five decades of use in epilepsy: Time to reconsider the indications of a time-honoured drug 104
DIFFERENTIAL-EFFECTS OF VALPROIC ACID AND ENZYME-INDUCING ANTICONVULSANTS ON NIMODIPINE PHARMACOKINETICS IN EPILEPTIC PATIENTS 104
Add-on lamotrigine treatment in children and young adults with severe partial epilepsy: a open, prospective, long-term study 102
Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects 102
Epilessia nell'anziano:dati dai registri di un centro neurologico. 102
Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects 101
Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey. 101
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction 100
Can drug resistance in epilepsy be minimized? Challenging commonly held beliefs. 100
A pragmatic algorithm to select appropriate antiseizure medications in patients with epilepsy 100
CYP2D6-related oxidation polymorphism in Italy 100
Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine. 100
Overtreatment in epilepsy: adverse consequences and mechanisms. 99
The Influence of Dosage, Age, and Comedication on Steady State Plasma Lamotrigine Concentrations in Epileptic Children 99
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. 99
Withdrawing antiepileptic drugs in seizure-free patients: what are the cognitive benefits? 98
Fetal exposure to GABA-acting antiepileptic drugs generates hippocampal and cortical dysplasias. 98
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: A clinically relevant pharmacokinetic drug interaction 98
Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries 97
Erratum The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: The PuLsE (Open Prospective Randomized Long-term Effectiveness) trial (Epilepsia (2014) 55 (893-900) 97
Farmacocinetica delle benzodiazepine. 97
A new classification is born 97
Vigabatrin and epilepsy. Lessons learned. 96
The remarkable story of valproic acid 96
A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV) 96
Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders 95
Plasma gabapentin concentrations in children with epilepsy: Influence of age, relationship with dosage, and preliminary observations on correlation with clinical response 95
Epilepsy: new advances. 95
Topiramate pharmacokinetics in children and adults with epilepsy: A case-matched comparison based on therapeutic drug monitoring data. 95
Daytime sleepiness in epileptic patients on long-term monotherapy: MSLT, clinical and psychometric assessment 95
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 95
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes 95
The management of refractory idiopathic epilepsies 94
Revisiting phenobarbital for epilepsy. 94
Role of valproate across the ages. Treatment of epilepsy in the elderly 94
What clinical trial designs have been used to test antiepileptic drugs and do we need to change them? 94
When clinical trials make history: Demonstrating efficacy of new antiepileptic drugs as monotherapy. 94
Totale 11.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 0 0 0 0 0 98
2021/20221.632 31 5 64 21 20 36 27 101 100 18 275 934
2022/20235.273 641 314 37 471 518 593 0 355 2.110 25 136 73
2023/20241.577 222 281 58 137 170 413 30 107 11 45 60 43
2024/20254.438 141 480 126 178 74 186 145 366 978 166 477 1.121
2025/202611.560 786 1.085 1.420 1.059 1.177 460 2.312 467 873 833 759 329
Totale 34.570